This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration, specifically the Veterans Integrated Service Network (VISN) 2, to Walgreens Specialty Pharmacy, LLC. The contract is for the delivery of the medication Jynarque (tolvaptan) 45/15mg tablets, which is used to treat autosomal dominant polycystic kidney disease. The contract has a ceiling value of $13,242.99 and a performance period ending on June 18, 2025. The contract is a non-set-aside award, meaning it is open to all qualified vendors. Walgreens Specialty Pharmacy, LLC is a subsidiary of the larger Walgreens retail pharmacy chain and specializes in providing complex and specialized pharmaceutical products to federal agencies, particularly the VA.
Generated 3/25/25, 9:47 AM